(19)
(11) EP 2 023 912 A2

(12)

(88) Date of publication A3:
03.07.2008

(43) Date of publication:
18.02.2009 Bulletin 2009/08

(21) Application number: 07795353.7

(22) Date of filing: 24.05.2007
(51) International Patent Classification (IPC): 
A61K 31/165(2006.01)
A61K 31/19(2006.01)
A61P 7/06(2006.01)
A61P 35/00(2006.01)
A61K 31/17(2006.01)
A61K 31/454(2006.01)
A61P 35/02(2006.01)
(86) International application number:
PCT/US2007/012495
(87) International publication number:
WO 2007/139939 (06.12.2007 Gazette 2007/49)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 26.05.2006 US 808602 P

(71) Applicant: CELGENE CORPORATION
Summit, NJ 07901 (US)

(72) Inventors:
  • VERHELLE, Dominique
    San Diego, CA 92130 (US)
  • CHAN, Kyle
    San Diego, CA 92130 (US)
  • CORRAL, Laura
    San Diego, CA 92122 (US)
  • MOUTOUH DE PARSEVAL, Laure
    La Jolla, CA 92037 (US)
  • BRADY, Helen
    San Diego, CA 92128 (US)

(74) Representative: Jones Day 
Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11
80538 München
80538 München (DE)

   


(54) METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS IN COMBINATION THERAPY